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Rodent (Muridae: Sigmodontinae) blood and sera collected from 14 states were tested for seroreactivity to
a cultured isolate of the human granulocytic ehrlichiosis (HGE) agent by using an indirect immunofluores-
cence assay. Of the 1,240 samples tested, 136 (11%) were found to be reactive at titers of >32. Rodents with
HGE agent-specific antibodies were found in New York (23% of 491 samples; geometric mean endpoint titer
[GMT] 5 441), Connecticut (11% of 100 samples; GMT 5 481), California (9% of 32 samples; GMT 5 323),
Colorado (2% of 212 samples; GMT 5 256), Florida (7% of 27 samples; GMT 5 362), Maryland (7% of 15
samples; titer 5 64), New Jersey (4% of 76 samples; titer 5 256), and Wisconsin (13% of 8 samples; titer 5
128). Samples from Georgia (n 5 16), Illinois (n 5 27), Nevada (n 5 27), North Carolina (n 5 52), Ohio (n 5
57), and Utah (n 5 100) were not reactive. The earliest seroreactive sample was from a Peromyscus leucopus
mouse collected in June 1986 in Connecticut, and the majority of the seroreactive samples (68%) were from this
species. Samples from other Peromyscus species (P. boylii, P. maniculatus, and P. gossypinus) were also found to
be reactive, with a GMT for the genus of 410. Several species of Neotoma woodrats (N. fuscipes, N. lepida, N.
albigula, and N. mexicana) from California and Colorado had antibodies that reacted with the HGE agent
(genus GMT 5 194), suggesting that enzootic cycles of Ehrlichia spp. exist outside of the areas of confirmed
human disease. Attempts to amplify and detect ehrlichial DNA from the limited tissues available (n 5 40
animals) were unsuccessful. Further studies are needed to determine the identity of the organisms inducing
antibody production in these rodent species and to elucidate the epidemiology and public health importance
of these agents.
Human ehrlichiosis may result from infection by at least four
ehrlichial agents. Ehrlichia sennetsu is not known to occur in
the United States (13), and an ehrlichial agent identified as
Ehrlichia canis may cause subclinical infections in humans in
Venezuela (24). Two forms of human ehrlichiosis have been
recognized in the United States during the last decade. The
first human case, initially thought to be due to infection with
E. canis, was recognized in the United States in 1986, and more
than 400 human cases due to Ehrlichia chaffeensis have since
been reported (8). Human granulocytic ehrlichiosis (HGE)
was first described in 1994 on the basis of findings from a series
of patients observed in Wisconsin and Minnesota from 1990
to 1993 (9). Since then, about 170 cases have been diagnosed
in patients in Arkansas, California, Connecticut, Florida, Mary-
land, Massachusetts, Minnesota, New York, Pennsylvania, Rhode
Island, and Wisconsin (29). Serologic evidence for infection by
the HGE agent or by a closely related agent has been reported
from Norway (3), Switzerland (5), and the United Kingdom
(26).
The agent or agents responsible for these HGE cases have
not been fully characterized. Ehrlichia equi and other members
of the Ehrlichia phagocytophila genogroup are very closely re-
lated, if not conspecific, organisms. Serologic (12), animal
transfer (18), and genetic (9) evidence indicates that these taxa
represent a single species. Much of the genetic similarity is
based on sequence analyses of the 16S rRNA gene. Further
analysis of additional gene sequences, complemented by ani-
mal infection and antigenic analyses, is needed to clarify the
taxonomic positions of these agents.
Little information is available concerning the natural history
of the HGE agent and similar ehrlichial organisms. The only
known maintenance or natural hosts of other ehrlichiae are
wild and domestic mammals. However, as most ehrlichiae have
been described from observations of clinically ill domestic
hosts, the natural reservoir hosts of the agents remain uncer-
tain. Epidemiologic evidence from the initial HGE case series
suggested that blacklegged ticks (Ixodes scapularis) or Ameri-
can dog ticks (Dermacentor variabilis) might be the vector spe-
cies responsible for transmission (2, 29). Subsequently, DNA
of the HGE agent was amplified from I. scapularis by PCR
assays (23) and from laboratory-reared ticks that fed upon wild
white-footed mice (Peromyscus leucopus) caught in an area
where HGE is endemic (27). Infected Peromyscus mice have
been identified within the geographic range of the northern
subspecies, P. leucopus noveboracensis, thus suggesting that this
subspecies may serve as the primary reservoir host in the
northeastern United States. The identification of a putative
vertebrate reservoir and a tick vector for the HGE agent that
are identical to those involved in the maintenance and trans-
mission of Borrelia burgdorferi has led to the expectation that
the epidemiology of HGE may be similar to that of Lyme
borreliosis.
Recent success in the in vitro propagation of E. equi and the
HGE agent has led to the development of serologic assays (14,
21, 22) which provide rapid and inexpensive ways to identify
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antibodies reactive to the HGE agent in humans and wild or
domestic animals that might serve as potential reservoir hosts.
Identification of the reservoirs of these organisms will provide
insight into the ecology and natural transmission cycles of
ehrlichiae and thereby facilitate the development of preventa-
tive measures to reduce human and animal exposure to these
potentially life-threatening pathogens. In this study, we tested
samples from sigmodontine rodents (Peromyscus spp. and Neo-
toma spp.) collected from several areas of the United States for
antibodies reactive with the HGE agent.
MATERIALS AND METHODS
Samples. Four geographic regions in the United States were selected for
serologic testing based on the hypothesis that the seroprevalence in the rodents
would be associated with the estimated relative abundances of the expected
vector (I. scapularis) and the expected rodent reservoir host (P. leucopus nove-
boracensis) of the HGE agent. Available samples from states within these regions
were categorized as (i) areas where both the expected host and the tick were
common (Connecticut, Maryland, New Jersey, New York, and Wisconsin), (ii)
areas where both the expected host and tick were absent (California, Colorado,
Nevada, and Utah), (iii) areas where the reservoir host was common and the tick
was uncommon (Ohio and Illinois), and (iv) areas where the tick was common
but the rodent host was uncommon or absent (Georgia, Florida, and North
Carolina). Samples were made available through the archival serum bank of the
Special Pathogens Branch of the Centers for Disease Control and Prevention
and from several additional donors. Rodent samples collected over the period
from 1986 to 1996 were provided to us from the following 14 states: California
(n 5 32), Colorado (n 5 212), Connecticut (n 5 100), Florida (n 5 27), Georgia
(n 5 16), Illinois (n 5 27), Maryland (n 5 15), Nevada (n 5 27), New Jersey (n 5
76), New York (n 5 491), North Carolina (n 5 52), Ohio (n 5 57), Utah (n 5
100), and Wisconsin (n 5 8). Most samples had been acquired during early
studies of hantavirus pulmonary syndrome in the United States (10) and were
stored frozen (270°C) as 1/32 dilutions (one batch was stored as a 1/25 dilution)
of sera or whole blood in a diluent consisting of phosphate-buffered saline (PBS;
pH 7.4), 0.5% Tween 20, 0.01% thimerosal, and 5% skim milk. All tested
samples were negative by enzyme-linked immunosorbent assay for the antibody
to the hantavirus nucleocapsid antigen. Diluted samples were thawed overnight
at 4°C and then mixed. The milk solids were allowed to settle, and an aliquot of
the test samples was removed from the clarified specimen (initial studies had
shown that excess milk solids would result in higher backgrounds).
IFA. Antigen for the indirect immunofluorescence assay (IFA) was kindly
provided by Aquila Biopharmaceuticals (Worcester, Mass.) as human promyelo-
cytes (HL-60) infected with a tick-derived isolate (USG3) of the HGE agent (11).
The preparation of antigen slides and the assay details have been described
previously (22). Briefly, the infected cells were allowed to adhere to the glass
surface. Excess growth medium was removed, and slides were air dried. Antigen
was fixed to the slides by immersion in acetone for 15 min. Slides were stored
dessicated at 270°C until used.
Sera or plasma from 1,240 sigmodontine rodents representing five species in
the genus Peromyscus and seven species in the genus Neotoma were tested for
antibodies reactive with the cultured isolate of the HGE agent. All samples were
initially screened at the lowest available common dilution (1/32). Twofold serial
dilutions of reactive samples were made in diluent (0.01 M PBS, 1% bovine
serum albumin, 1% normal goat serum, pH 7.4), and an endpoint titer was de-
termined. Positive control serum was obtained from a naturally infected P. leu-
copus mouse from Rhode Island (31), where infection was confirmed by PCR
detection of HGE agent DNA. Negative control sera were collected from labo-
ratory-reared P. leucopus mice (Peromyscus Genetic Stock Center, University of
South Carolina, Columbia, S.C.). Positive, negative, and diluent controls were
included on each slide. Optimal concentrations of reagents were determined by
checkerboard titration of these controls. Slides were incubated at 37°C for 30 min
and then washed three times for 5 min each with PBS. Fluorescein isothiocya-
nate-conjugated goat anti-P. leucopus immunoglobulin G (heavy plus light
chains; Kirkegaard & Perry Laboratories, Gaithersburg, Md.) diluted 1/25 was
applied to each well, and the slides were incubated and washed as described
above. During the next-to-last wash, Eriochrome Black T solution was added to
counterstain the host cells. Coverslips were mounted with 0.3 M 1,4-
diazabicyclo[2.2.2]octane in 10% PBS–90% glycerol buffer, and the slides were
examined with a UV epifluorescence microscope. Antibody titer was expressed
as the reciprocal of the last dilution exhibiting definite ehrlichial fluorescence.
The antibody titers were log2 transformed for comparisons of geometric mean
endpoint titers (GMT).
Because we have seen reactivity to the USG3 antigen in sera from some
humans with E. chaffeensis infection (22), all samples from mice collected in
Florida (n 5 27), Maryland (n 5 15), New Jersey (n 5 76), North Carolina (n 5
52), and Wisconsin (n 5 8) were tested against E. chaffeensis (Arkansas isolate)
(1) antigen in a similar IFA. All other assay conditions and reagents were as
described for the HGE testing.
PCR assays. Corresponding tissue samples were available for only 40 animals.
Rodent liver (n 5 9), lung (n 5 3), spleen (n 5 23), and whole-blood (n 5 5)
samples were processed for DNA extraction. Fifty microliters of whole blood or
a small piece of tissue (ca. 5 by 5 by 5 mm) was mixed with 300 ml of 10 mM Tris
saline buffer containing 1% sodium dodecyl sulfate and 100 ng of proteinase K
per ml. The suspension was incubated at 55°C for 2 h to digest proteins. The
material was extracted three times with phenol-chloroform-isoamyl alcohol (25:
24:1), and the aqueous supernatant was added to Centricon-30 centrifugation
units (Amicon, Beverly, Mass.). The DNA solution was washed three times with
10 mM Tris saline buffer, and the final volume was adjusted to 100 ml. The
extracted DNA was refrigerated (ca. 1 week) until it was tested in the PCR assay.
All PCR assays were prepared by using commercial amplification kits (Gene-
Amp; Roche Molecular Systems, Branchburg, N.J.). Ten microliters of DNA
template was added to a buffer containing 100 mM Tris-HCl (pH 8.3), 50 mM
KCl, 0.15 mM MgCl2, 0.001% gelatin, a 200 mM concentration of each dNTP, a
1 mM concentration of each primer, and 2.5 U of Taq polymerase. The primers
used were GE9 and GE10 (9), modified to include restriction sites to facilitate
cloning. The reaction mixture was overlaid with 50 ml of mineral oil and cycled
(Thermal Cycler; Perkin-Elmer Cetus, Norwalk, Conn.) for three preliminary
cycles (94°C for 1 min, 55°C for 2 min, and 72°C for 1.5 min), followed by 37
amplification cycles (88°C for 1 min, 55°C for 2 min, and 72°C for 1.5 min) and
then by an additional extension period of 5 min at 72°C. A nested reaction was
conducted for a total of 40 cycles with the universal 16S rRNA primers EC9 and
EC12 (1) in the first round and primers GE9 and GE10 in the second round (40
cycles). During the first amplification, the annealing temperature of the reaction
was lowered to 48°C and the extension temperature was lowered to 68°C. Dili-
gent laboratory procedures were applied to minimize environmental contamina-
tion. Positive (USG3 DNA), negative (E. chaffeensis DNA), and water controls
were included in each assay. Ten microliters of each PCR product was added to
sample wells of gels containing 1% agarose in 0.04 M Tris-acetate–0.01 M EDTA
(TAE) buffer, pH 8.4, and gel electrophoresis was conducted for 1 h at 125 V in
TAE buffer. The ethidium bromide-stained gels were photographed under short-
wave UV (300-nm) illumination.
The presence of inhibitors to the PCR was assessed by adding positive control
DNA from the HGE agent (USG3 isolate) to negative samples and retesting
them in the assay. When inhibition was noted, we tested a dilution series of
USG3 DNA that was spiked with several dilutions of pooled rodent DNA. The
USG3 dilution series was carried out until the ehrlichial DNA could no longer be
detected. The relative level of detection of ehrlichial DNA diluted in Tris saline
buffer was compared to the relative level of detection in series that had been
spiked with rodent DNA. The results of these experiments were used to deter-
mine the minimum dilution of rodent sample necessary to eliminate noticeable
inhibition of the PCR. The rodent samples were again tested after diluting them
1/20 in Tris saline buffer.
RESULTS
Occurrence of HGE antibodies in rodent serum and blood
samples. None of the 16 serum samples from laboratory-
reared P. leucopus mice reacted with the USG3 antigen at a
1/16 dilution, and a pool of three sera was aliquoted for use as
test controls. The positive control sample had an end point
titer of 512 and gave a reaction pattern similar to that seen for
sera from HGE cases (22). The overall amount of nonspecific
binding of the rodent samples to the HL-60 cells was less than
the very low level observed in most human sera. No difference
in reactivity or background fluorescence among serum, plasma,
and blood samples was noted.
Of the 1,240 specimens from wild rodents assayed, 136 (11%)
had antibodies reactive with the HGE agent at the screening
dilution of 1/32 (Table 1). None of the 178 mice collected in
Florida, Maryland, New Jersey, North Carolina, and Wisconsin
had antibodies that were reactive against E. chaffeensis antigen,
suggesting that this reactivity was not due to cross-reaction
with E. chaffeensis.
Genus Peromyscus. Of the 1,095 rodents of the genus Pero-
myscus tested, 131 (12%) had antibodies reactive with the
HGE agent (Table 1). Specific P. leucopus antibodies were
found in mice collected in Connecticut (11 of 100), Maryland
(1 of 15), New Jersey (1 of 23), New York (113 of 491), and
Wisconsin (1 of 8), but not in mice collected in Colorado,
Georgia, Illinois, North Carolina, or Ohio (Table 2). Other
members of the genus found to have antibodies reactive with
the HGE agent were P. gossypinus (2 of 26) in Florida and P.
boylii (1 of 9) and P. maniculatus (1 of 17) in Colorado.
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Genus Neotoma. Of the 130 rodents of the genus Neotoma
tested, five (4%) had antibodies reactive with the HGE agent
(Table 1). All of the rodents of this genus tested were collected
from California and Colorado. Seroreactive N. albigula (1 of
72) and N. mexicana (1 of 21) samples were found in Colorado,
while reactive N. fuscipes (2 of 23) and N. lepida (1 of 4)
samples were found in California (Table 2). No N. cinerea (n 5
2), N. fallax (n 5 1), or N. micropus (n 5 7) samples were sero-
reactive.
Frequency distribution of antibody titers. End point titers in
the seroreactive rodents ranged from 32 to 4,096, with a modal
titer of 512 (Fig. 1). Overall, 58% of seroreactive samples had
titers of $512. Rodents from the genus Peromyscus had titers
that ranged from 32 to 4,096 (GMT 5 410). P. leucopus was the
only species with end point titers of $1,024. Samples from ro-
dents of the genus Neotoma had titers that ranged from 32 to
512 (GMT 5 194).
Seroreactive samples were found from rodents collected in
1986, 1991, 1993, 1995, and 1996, indicating that infections due
to HGE or HGE-like organisms were occurring in rodents
for several years prior to the first recognition of human HGE
cases. The earliest seroreactive sample in our material was
acquired from a white-footed mouse, P. leucopus (titer of
2,048), collected in June 1986 from East Haddam, Conn.
Geographic distribution. The highest percentages of anti-
body-positive specimens were from the areas where both the
putative reservoir and vector coexisted (Table 3). Of the 690
specimens tested from this region, 127 (18%) reacted to the
HGE agent at titers ranging from 32 to 4,096. The largest
proportion (40%) of the samples from this region was collected
in New York, and 113 (83%) of the total of 136 seroreactive
samples were identified from this state. Seroreactive P. leuco-
pus mice were also found in Connecticut, New Jersey, and
Wisconsin, states where HGE is known to occur.
In the region where the putative vector was common or
present but where P. leucopus noveboracensis was uncommon
or absent, only 2 (2%) of 95 rodent samples were seroreactive
to the HGE agent. Two P. gossypinus samples from Florida had
titers of 256 and 512, and both of the rodents were caught in
Dade County. No seroreactive animal was found in the region
where the expected vector was uncommon or absent and the
expected rodent reservoir was present.
In the region where both the putative vector and putative
reservoir were absent, 7 (2%) of 371 sera from six different
species reacted with the HGE antigen. Three (9%) of 32 Cali-
fornia Neotoma samples and 4 (1.9%) of 212 Colorado wood-
rat and Peromyscus sp. samples possessed antibodies to the
HGE agent. Two of the three positive woodrat samples from
California, from N. fuscipes and N. lepida, were obtained in San
Diego County, and both had titers of 512. The third sample was
from an N. fuscipes woodrat from urban Los Angeles County
and had a titer of 128. The four seroreactive rodent samples
from Colorado were collected from widely separated counties
and habitats: seroreactive N. mexicana and P. boylii animals
originated from the grasslands of southern Las Animas Coun-
ty; one P. maniculatus mouse came from Hesperus Mountain
TABLE 1. Rodent species tested for antibodies
reactive to the HGE agent
Species n % oftotal
No. reactive
(%)a Titer
P. boylii 10 0.9 1 (10) 256
P. eremicus 1 0.1 0
P. gossypinus 27 2.5 2 (7.4) 362 (256–512)b
P. leucopus 838 76.5 127 (15.2) 414 (32–4,096)b
P. maniculatus 211 19.3 1 (0.5) 256
Peromyscus spp. 23 2.1 0
Total 1,095 131 (12) 410 (32–4,096)b
N. albigula 72 55.4 1 (1.4) 32
N. cinerea 2 1.5 0
N. fallax 1 0.8 0
N. fuscipes 23 17.7 2 (8.7) 256 (128–512)b
N. lepida 4 3.1 1 (25) 512
N. mexicana 21 16.2 1 (4.8) 256
N. micropus 7 5.4 0
Total 130 5 (3.8) 194 (32–512)b
Grand total 1,240 136 (11)
a IFA titer of $32.
b GMT (range) of seroreactive (IFA titer $32) samples.
TABLE 2. Geographic distribution of rodents tested
for antibodies reactive to the HGE agent
State Species n % of statetotal
No. reactive
(%)a
California N. fallax 1 3.1 0
N. fuscipes 23 71.9 2 (8.7)
N. lepida 4 12.5 1 (25)
P. boylii 1 3.1 0
P. eremicus 1 3.1 0
P. maniculatus 2 6.3 0
Subtotal 32 3 (9.4)
Colorado N. albigula 72 33.9 1 (1.4)
N. cinerea 2 0.9 0
N. mexicana 21 9.9 1 (4.8)
N. micropus 7 3.3 0
P. boylii 9 4.2 1 (11.1)
P. leucopus 84 39.6 0
P. maniculatus 17 8 1 (5.9)
Subtotal 212 4 (1.9)
Connecticut P. leucopus 100 100 11 (11.0)
Subtotal 100 11 (11.0)
Florida P. gossypinus 27 100 2 (7.4)
Subtotal 27 2 (7.4)
Georgia P. leucopus 14 87.5 0
Peromyscus spp. 2 12.5 0
Subtotal 16 0
Illinois P. leucopus 15 55.6 0
P. maniculatus 9 33.3 0
Peromyscus spp. 3 11.1 0
Subtotal 27 0
Maryland P. leucopus 15 100 1 (6.7)
Subtotal 15 1 (6.7)
Nevada P. maniculatus 27 100 0
Subtotal 27 0
New Jersey P. leucopus 23 30.3 1 (4.3)
P. maniculatus 53 69.7 0
Subtotal 76 1 (1.3)
New York P. leucopus 491 100 113 (23.0)
Subtotal 491 113 (23.0)
North Carolina P. leucopus 52 100 0
Subtotal 52 0
Ohio P. leucopus 36 63.2 0
P. maniculatus 3 5.3 0
Peromyscus spp. 18 31.6 0
Subtotal 57 0
Utah P. maniculatus 100 100 0
Subtotal 100 0
Wisconsin P. leucopus 8 100 1 (12.5)
Subtotal 8 1 (12.5)
Total of all states 1,240 136 (11.0)
a IFA titer of $32.
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located in Montezuma County in southwestern Colorado; and
one N. albigula woodrat came from the more mountainous
region of Larimer County in north central Colorado. The sam-
ple from the last animal had a low titer (32 by IFA), whereas
samples from the other Colorado rodents had titers of 256.
PCR assays. Tissues and blood from both seropositive and
seronegative rodents were limited in availability. Forty organ
tissue or whole-blood samples from rodents in Colorado, Flor-
ida, Maryland, New Jersey, and Wisconsin were extracted, and
the DNA was tested by PCR assays. No bands of the expected
size (919 bp) were amplified from the tissues by using the 16S
rRNA primers GE9 and GE10 in a one-step PCR, or with GE9
and GE10 after EC9 and EC12 in the nested PCR. Samples
were tested twice in each assay. Upon further investigation, we
found that many of the DNA samples were inhibitory to the
PCR. Because excess rodent DNA might be the cause of the
inhibition, we spiked a dilution series of DNA from the HGE
agent with a series of dilutions of our rodent DNA. We deter-
mined that dilution of the samples 1/20 in Tris saline buffer was
sufficient to reduce the inhibition to a undetectable level. Thus,
all samples were again assayed as before, with the rodent DNA
samples at 1/20 dilutions. No tissue was found to be positive
after the inhibition was removed.
DISCUSSION
This study provides additional evidence implicating white-
footed mice in a transmission cycle of HGE whereby I. scapu-
laris ticks transmit the agents to humans. Other mammals may
be shown to play a role, but our efforts largely focused on two
genera of rodents. The majority of our seroreactive animals
and the highest prevalences of antibodies were observed in lo-
cations where this tick and P. leucopus were common. In addi-
tion, this study provides the first evidence that the HGE agent
or other HGE-like agents are widely distributed throughout
the United States. It also provides the first evidence that HGE-
like agents may be associated with the genus Neotoma in the
western United States.
We hypothesized that if the HGE agent was monotypic and
had coevolved with specific hosts and vectors, then seroreactive
mice would be limited to areas where the geographic ranges of
the putative vector and putative reservoir host overlap. The
expected enzootic cycle was defined as transmission among
P. leucopus noveboracensis mice through the bites of I. sca-
pularis ticks, as has been indicated by the known geographic
range of HGE cases (29) and supported by preliminary obser-
vations (23, 27). Therefore, the estimated relative abundances
of these two species in different geographic locations of the
United States guided our selection of samples for this study.
For example, Wisconsin was chosen as a site where both the
tick and the rodent subspecies coexist, while Utah was chosen
as an area where neither is present. Although we recognize
that HGE cases have been reported from additional areas
where other hosts and vectors must be present, such as Cali-
fornia, this sampling strategy would also identify areas where
reservoir hosts and tick vectors for HGE or HGE-related or-
ganisms must be different from those in the hypothesized
transmission cycle. In this initial survey, woodrats were se-
lected for analysis where P. leucopus does not occur because
extra-Peromyscus cycles of B. burgdorferi transmission that in-
volve Neotoma spp. and their associated ticks have been found
(6, 20).
The seroprevalence of antibodies to the HGE agent was
highest among the rodents from states where HGE is known to
infect humans, ticks, or other animals. Although our sample
targeted the genus Peromyscus, specifically P. leucopus, we
found three additional species (P. maniculatus, P. gossypinus,
and P. boylii) with antibodies reactive to the HGE agent. Pre-
vious studies have suggested that P. leucopus could be the
principal reservoir host for the HGE agent in the northeast
and upper Midwest (27, 30), and our data support this conclu-
sion. We identified no seropositive P. leucopus mice outside of
the known distribution of the northern subspecies, P. leucopus
noveboracensis. However, our sample sizes were limited, and a
lower prevalence of infection with the HGE agent cannot be
excluded elsewhere in the geographic range of P. leucopus. If
we assume an expected prevalence of 23%, as was found in
New York, then the probability of obtaining 10 negative ani-
mals and no reactors at any locality is 0.07 based on the bino-
mial distribution. If the prevalence is actually lower, the power
of our sampling efforts to detect a single reactive animal would
be diminished and no conclusions can be drawn about the true
geographic distribution of seroreactive animals.
The IFA used detects antibodies reactive with the E. phago-
cytophila genogroup (E. phagocytophila, E. equi, and the HGE
FIG. 1. Frequencies of antibody titers to the USG3 antigen in Peromyscus
mice (n 5 131) and Neotoma woodrats (n 5 5) by IFA.
TABLE 3. Serologic test results grouped by state and by category
of hypothesized vector and reservoir abundances
Category
(vector/re-
servoir)a
State
% of
cate-
gory
n (%)
No.
reactiveb
(%)
Titer
CP/CP Connecticut 14.5 100 11 (11.0) 481 (128–2,048)c
New Jersey 11.0 76 1 (1.3) 256
New York 71.2 491 113 (23.0) 419 (32–4,096)c
Maryland 2.2 15 1 (6.7) 64
Wisconsin 1.1 8 1 (12.5) 128
Total 690 (55.6) 127 (18.4)
CP/UA Florida 28.4 27 2 (7.4) 362 (256–512)c
Georgia 16.8 16 0
North Carolina 54.7 52 0
Total 95 (7.7) 2 (2.1)
UA/CP Illinois 32.1 27 0
Ohio 67.9 57 0
Total 84 (6.8) 0 (0.0)
UA/UA California 8.6 32 3 (9.4) 323 (128–512)c
Colorado 57.1 212 4 (1.9) 256 (32–256)c
Nevada 7.3 27 0
Utah 27.0 100 0
Total 371 (30.0) 7 (1.9)
a Estimated relative abundances of I. scapularis and P. leucopus noveboracensis
as hypothesized in the text. CP, common or present; UA, uncommon or absent.
b IFA titer of $32.
c GMT (range) of reactive samples.
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agent). No significant detectable reactivity has been noted with
sera containing antibodies to E. canis, E. risticii, E. sennetsu, or
several rickettsial organisms (22). Although a limited number
of human sera with increased levels of antibodies to E. chaf-
feensis can react with the antigen (22), rodents have never been
found to have naturally occurring antibodies to E. chaffeensis
(8a). Accordingly, all mice from our study collected in Florida,
Maryland, New Jersey, North Carolina, and Wisconsin were
nonreactive when tested with E. chaffeensis antigen in an IFA.
Nevertheless, we cannot exclude infection by an as yet uniden-
tified member of the E. phagocytophila genogroup.
The specific fluorescence observed indicated infection with
organisms antigenically identical or closely related to the HGE
agent. The GMT of the Peromyscus spp. (410) was greater than
that of the Neotoma spp. (194), suggesting that ehrlichial agents
associated with Neotoma species may be antigenically different
from the HGE agent or that the immune response is reduced
in woodrats. It should be noted that the number of seroreactive
samples for the Neotoma woodrats was small. Also, the conju-
gate was produced against P. leucopus immunoglobulins and
may have resulted in slightly lower titers with heterologous
sera, although prior testing had shown this reagent to be useful
in the detection of Peromyscus and Neotoma antibodies (10).
Our data suggest that high prevalences of host infection (up
to 23%) occur in certain geographic locations. GMTs of Pero-
myscus spp. from areas where HGE is endemic in the United
States were greater than those from other regions of the coun-
try. However, this finding could also be due to the substantial
contribution of P. leucopus from states where HGE is endemic
to the overall sample. The majority of seroreactive P. leucopus
mice were from New York and Connecticut, and they may
have been infected with a strain of the HGE agent more
similar to the isolate we used (originating from ticks in Penn-
sylvania and New York), thus resulting in higher titers to a
homologous antigen.
The prevalence of specific antibodies to HGE or related
organisms detected in wild rodents has ranged from about 10%
in Minnesota (30) to only 1.8% in a marginal urban habitat of
Maryland (7). Other investigators have also found a high prev-
alence of infection among the putative vector ticks that feed
upon these hosts. Using a PCR assay, Pancholi and coworkers
(23) found a single positive I. scapularis tick collected from a
deer near Spooner, Wis., in 1982. In our study, we detected
specific antibodies in a mouse collected from that vicinity. In a
field collection of 15 P. leucopus mice on Nantucket Island, 5
mice were found to be capable of infecting laboratory-reared I.
scapularis nymphs with the HGE agent, suggesting a minimum
prevalence of 33% in the rodents (27). In the Connecticut
towns of Bridgeport, East Haddam, and Lyme during the au-
tumn of 1994 (19), the agent of HGE was detected by PCR
assay in 50% of 118 adult I. scapularis ticks. In our study, the
townships of East Haddam and Lyme were where two samples
(titers of 2,048) were obtained in 1986 and 1990, respectively,
consistent with an established mouse-Ehrlichia relationship.
In the United States, wild rodents have not previously been
implicated in the epidemiology of any ehrlichial disease other
than HGE, although they may serve as experimental hosts for
several ehrlichiae. A monocytic species, Ehrlichia muris, was
isolated from the spleen of a mouse (Eothenomys kageus) in
Japan (17), but no human cases due to this agent have been
identified. Granulocytic ehrlichiae have been discovered in a
Gambian giant rat (Cricetomys gambianus) (15), and an agent
morphologically similar to the HGE agent was discovered in
meadow voles (Microtus pennsylvanicus) and P. leucopus mice
from Nantucket, Mass. (28). This agent, designated “Cytoecetes
microti,” was readily passaged among these rodents and the
desert mouse, Peromyscus eremicus.
The identification of numerous seroreactive species in the
genera Peromyscus and Neotoma suggests that multiple enzo-
otic cycles for maintaining granulocytic ehrlichiae exist and
that alternative vertebrate hosts or tick vectors will be identi-
fied in geographic areas outside of the northeast and Midwest
foci of HGE. Currently there are limited data to suggest that
human infection or disease is present in many of these regions
where other vertebrate hosts or vectors occur, but our under-
standing of the epidemiology of HGE is incomplete. Whether
multiple ehrlichial species exist or whether a single species is
being maintained in numerous rodent species warrants further
study.
Some data suggest that alternative vertebrate host and vec-
tor maintenance cycles may be epidemiologically relevant to
human ehrlichiosis, as Peromyscus species from Florida and
Colorado were found to have specific antibodies. Serologic
evidence suggests that human infection by an HGE-like agent
has occurred in Florida (13), and P. leucopus does not occur
there. In 1984, an E. equi-like agent was reported from north-
ern Florida in a horse fed upon by two I. scapularis ticks at the
time of diagnosis (4). The presence of seroreactive cotton mice
(P. gossypinus) from this state deserves further attention. In
Colorado, the findings from P. boylii and P. maniculatus are
significant because, although no human HGE cases are known,
equine ehrlichiosis has been recorded from that state (4).
Four species of Neotoma woodrats (N. albigula, N. fuscipes,
N. lepida, and N. mexicana) were found to have evidence of
exposure to HGE-like species in California and Colorado.
Enzootic transmission cycles involving woodrats for the tick-
transmitted human pathogen B. burgdorferi in areas outside the
distributions of P. leucopus and I. scapularis have been de-
scribed (6, 20). These additional cycles may persist enzootically
with no human association, but can become epidemiologically
important when “bridge vectors” enter the cycle. Bridge vec-
tors can serve as secondary vectors of human pathogens by
feeding on both the enzootic host and humans. In California,
B. burgdorferi is maintained in an enzootic cycle involving
Ixodes neotomae and its woodrat host, N. fuscipes (6). The
spirochete can be transmitted to humans only when Ixodes
pacificus enters these cycles and serves as the bridge to hu-
mans. Maupin et al. (20) discovered a similar cycle in Colorado
involving the Mexican woodrat, N. mexicana, and the tick
Ixodes spinipalpis (which may be conspecific with I. neotomae).
The finding of seroreactive woodrats from California raises
the possibility that woodrats could be an undiscovered natural
reservoir of the veterinary pathogen E. equi in the western
United States. The taxonomic relationship between E. equi and
the HGE agent is extremely close. The 16S rRNA gene se-
quences of E. equi from horses in the United States have only
shown a 1- or 2-base difference from that of the HGE agent (1,
14), although Ehrlichia organisms from horses in Sweden have
16S rRNA gene sequences identical to that of the HGE agent
(16). No reservoir host or vector for E. equi has been identified,
but I. pacificus may experimentally transmit the organism
among horses (25).
We were unable to amplify specific DNA of granulocytic
ehrlichiae from any rodent tissue tested. Additional studies
revealed that PCR inhibition was present in many of the wild-
rodent DNA samples. Dilution of the samples eliminated in-
hibition of the PCR as determined by spiking experiments, but
this dilution might have affected our assay sensitivity. Unfor-
tunately, only small quantities of whole blood or tissues were
available for testing, thus limiting our ability to detect samples
containing small amounts of ehrlichial DNA. Furthermore, we
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had a limited number of samples available for testing, and
assays of additional samples may have increased our chances of
detecting DNA from any HGE-like agent. Other studies have
found a low prevalence of amplifiable ehrlichial DNA present
in HGE antibody-positive mice (30). Further studies utilizing
laboratory infections will be required to determine the optimal
tissues for PCR testing, the timing of samples, and the relative
levels of ehrlichial DNA in different rodent tissues. The inclu-
sion of isolation attempts from wild rodents will be important
in furthering our understanding of the relationships among
these agents.
Human ehrlichiosis may continue to emerge as an important
zoonosis in the United States as humans intrude upon enzootic
cycles and as physician awareness of clinical human ehrlichiosis
increases. As the clinical spectrum of the human ehrlichioses
evolves and public health professionals become aware of the
potential for maintenance cycles other than the P. leucopus-
I. scapularis cycle in the northeast, we may discover human
disease due to granulocytic ehrlichiae in other regions of the
United States.
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